Hepatitis C: No Overall Difference In Sustained Viral Response In Most Widely Used Treatments, Duke University Medical Center Study

EurekAlert! -- DURHAM, N.C. – Findings from the largest study to date comparing the efficacy of competing treatments for chronic hepatitis C infection (HCV) show that the regimens are similar when it comes to safety and their ability to provoke long-term viral eradication, according to researchers at Duke University Medical Center. Still, subgroup analysis reveals provocative data suggesting some approaches might be better than others for women and minorities.